Fluoropharma Medical Stock Market Value
| FPMI Stock | USD 0.0002 0.00 0.00% |
| Symbol | Fluoropharma |
Fluoropharma Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fluoropharma Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fluoropharma Medical.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Fluoropharma Medical on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Fluoropharma Medical or generate 0.0% return on investment in Fluoropharma Medical over 90 days. FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of... More
Fluoropharma Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fluoropharma Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fluoropharma Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1174 | |||
| Maximum Drawdown | 100.0 |
Fluoropharma Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fluoropharma Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fluoropharma Medical's standard deviation. In reality, there are many statistical measures that can use Fluoropharma Medical historical prices to predict the future Fluoropharma Medical's volatility.| Risk Adjusted Performance | 0.1087 | |||
| Jensen Alpha | 1.42 | |||
| Total Risk Alpha | 0.5908 | |||
| Treynor Ratio | 1.07 |
Fluoropharma Medical February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1087 | |||
| Market Risk Adjusted Performance | 1.08 | |||
| Mean Deviation | 2.98 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 12.31 | |||
| Variance | 151.52 | |||
| Information Ratio | 0.1174 | |||
| Jensen Alpha | 1.42 | |||
| Total Risk Alpha | 0.5908 | |||
| Treynor Ratio | 1.07 | |||
| Maximum Drawdown | 100.0 | |||
| Skewness | 8.12 | |||
| Kurtosis | 66.0 |
Fluoropharma Medical Backtested Returns
Fluoropharma Medical is out of control given 3 months investment horizon. Fluoropharma Medical secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13 % return per unit of risk over the last 3 months. We have collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 1.56% are justified by taking the suggested risk. Use Fluoropharma Medical Mean Deviation of 2.98, variance of 151.52, and Standard Deviation of 12.31 to evaluate company specific risk that cannot be diversified away. Fluoropharma Medical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.41, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fluoropharma Medical will likely underperform. Use Fluoropharma Medical standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on Fluoropharma Medical.
Auto-correlation | 0.00 |
No correlation between past and present
Fluoropharma Medical has no correlation between past and present. Overlapping area represents the amount of predictability between Fluoropharma Medical time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fluoropharma Medical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Fluoropharma Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.